1 year ago
Drug Combination Extends Mouse Lifespan, Offers Anti-Aging Hope
Scientists have found that a mix of two existing drugs can help mice live longer and healthier lives.
These drugs, rapamycin and trametinib, are already used in medicine.
The mice that took the drugs had less inflammation and fewer tumors, and were more active.
Although this is good news, the scientists want to do more research.
They hope to improve the quality of life in older people, not just make them live longer.
More studies will be done to see if these drugs work in humans.
A combination of rapamycin and trametinib extended the lifespan of mice by up to 30 percent.
Mice showed reduced inflammation, delayed tumor growth, and better overall physical function.
Both drugs are approved for human use, potentially speeding up clinical trials.
The treatment targets the Ras/Insulin/TOR cellular pathway.
Researchers caution against immediate human application, citing complexity and potential risks.
- Who
- Scientists at the Max Planck Institute
- What
- A drug combination (rapamycin and trametinib) extended the lifespan and improved health of mice.
- Where
- Germany
- When
- Recently
- Why
- To explore anti-aging treatments for humans.
Key facts
- Drug Combination
- Rapamycin and trametinib
- Lifespan Increase (Mice)
- Up to 30%
- Health Benefits
- Reduced inflammation, delayed tumor growth, and improved physical function
- Current Use (Drugs)
- Cancer treatment (trametinib), prevent organ rejection (rapamycin)
- Study Location
- Max Planck Institute for Biology of Ageing, Germany
